Kwon, Kee Woong
Aceves-Sánchez, Michel de Jesús
Segura-Cerda, Cristian Alfredo
Choi, Eunsol
Bielefeldt-Ohmann, Helle
Shin, Sung Jae
Flores-Valdez, Mario Alberto
Funding for this research was provided by:
Korea Health Industry Development Institute (HV20C0139)
Ministry of Food and Drug Safety (22202MFDS173)
Article History
Received: 25 February 2022
Accepted: 7 September 2022
First Online: 22 September 2022
Competing interests
: M.A.F.V., M.J.A.S. have a patent issued for the BCGΔBCG1419c as vaccine candidate against tuberculosis. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.